Replies to post #23431 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Yes excellent point Samsa. We shall soon see how 2017 unfolds right. Like you I've been here for years so when the institutional accumulation wave begins we'll both be able to look back with a great deal of satisfaction knowing we believed in this company's eventual success.

Rexista will partner...Rexista version II will partner and the partner will pay for PODRAS development.

And once PODRAS is proven 2+ years from now every opioid and pain killer manufacturer out there will be approaching IPCI for PODRAS licensing deals right!

When I first discovered this stock I was expecting all their ANDA's to be approved by now and had my eyes set on the bigger NDA prizes to come. And PODRAS wasn't even in play yet when I firmly believed Dr Odidi's npodds delivery tech platform would earn IPCI a best-in-class designation on Rexista.

So needless to say despite all the roadblocks, challenges and hurdles that IPCI's had to overcome with the drawn out delayed generics approval process...we're finally going to be putting the development years behind us and 2017 is going to forever be looked back upon as the year IPCI finally began to hit the ground running right glty

[purefreewater]

thank you Samsa
( as well as for the other one that you answered for me a few weeks ago )

and thank you Doogdilinger


You (all) guys are great ! ...... This board is GREAT !!!!!




go IPCI